Hey @mart_bradley - yes, the BMJ is a well respected journal with a high impact factor. In other words NOT on a watch list for say predatory publishing.
OLP - yes, the lead author, Kaptchuk, has been examining open label placebos for quite some time. He’s also a co-author on a popular predictive processing paper here -
Symptom perception, placebo effects, and the Bayesian brain
There’s a lot to unpack regarding ethical usage of OLPs that I’ll refrain from getting into here. However, the overarching theme would be centered around necessity. Personally, I’d rather aid with folks realizng their own abilities for self-management. There are many factors influencing outcomes (as the paper discusses), so I’m not sold on the need to introduce a placebo (pill).
With that said, I appreciated their entering into the literature official definitions for future usage, as that in of itself has been an area of debate for a bit:
From Box 1:
Placebos are pills composed of inert substances (eg, microcrystalline cellulose) or sham procedures without any direct effect on pathophysiology
Placebo controls are simulated treatments (pills or procedures) designed to appear indistinguishable from the intervention under investigation while lacking the properties thought to be therapeutic
Placebo effects are the salubrious clinical outcomes patients derive from participation in the rituals, symbols, and behaviors of medical treatment. This descriptive definition avoids any premature inference about putative mechanism(s). The definition also avoids the oxymoronic idea of an “inert” substance causing symptom relief
Placebo responses are outcomes detected with placebo controls in randomized controlled trials that include both genuine placebo effects and such non-specific effects as regression to the mean, spontaneous improvement, and normal fluctuations in illness. Placebo responses also accompany most clinical interventions for subjective complaints
Placebo treatment is an inclusive term for different conditions under which placebos can be administered: double blind, deceptively, or honest open label
I also appreciated their 3 rationalizations for explaining placebo effects, albeit transposing these ideas to clinical practice pragmatically is a bit murky.
At any rate, Kaptchuk has an interesting history (I don’t mean this negatively) most aren’t likely familiar with but is cool to see how he has integrated into Harvard and carved out a niche for himself: https://www.tedkaptchuk.com/